CHICAGO–(BUSINESS WIRE)–FH Ortho, maker of thoughtfully designed orthopedic devices and instruments for surgeons around the world, today announced it has received approval from The U.S. Food and Drug Administration (FDA) […]
PARSIPPANY, NJ–(Marketwired – Jun 15, 2015) – Ogilvy CommonHealth Worldwide (www.ochww.com), the health behavior change specialists of Ogilvy & Mather (www.ogilvy.com), and a WPP company (NASDAQ: WPPGY) (www.wpp.com), today announced […]
Effort to Focus on Increasing Awareness of Preventable Heart Attacks and Strokes Among African-American Men ATLANTA, GA–(Marketwired – June 15, 2015) – Americans suffer 1.5 million heart attacks and strokes […]
New Poll of Veterinarians Shows That Proposed FDA Guidance on the Use of Medications That Are “Very Important” to Their Practices and to Patients’ Medical Outcome Would Have a Large Negative Impact on Them and Their Patients
Animal Health, FDA/Regulatory, Health, Healthcare Physicians, Healthcare/Medicare/MedicaidPHOENIX–(BUSINESS WIRE)–A new poll of veterinary practices that administer and prescribe customized medications for their patients confirms that new guidance proposed by the Food & Drug Administration (FDA) would have […]
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/vfslvt/global_vitamin) has announced the addition of the “Global Vitamin Ingredients Market in 2015-2019” report to their offering. Vitamins are organic compounds that are required by living […]
WASHINGTON, DC and BOSTON, MA–(Marketwired – June 15, 2015) – DIA 2015 Annual Meeting — BBK Worldwide, a leading clinical trial marketing firm, today announced My Research Mate℠, a live […]
CVS Health (CVS) said today it would buy the pharmacy and clinic business of retail giant Target (TGT) for $1.9 billion in a bold move to expand the CVS brand […]
WILMINGTON, Del.–(BUSINESS WIRE)–AstraZeneca (NYSE: AZN) today presented at the European League Against Rheumatism Annual Congress (EULAR 2015) in Rome, results of its Phase III double-blind, multicenter, placebo-controlled trial CRYSTAL, investigating […]
VIENNA & CAMBRIDGE, Mass.–(BUSINESS WIRE)–bluebird bio, Inc. (Nasdaq: BLUE), a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic and rare diseases and T cell-based immunotherapies, today announced […]
The NBA’s been dealing with a painful storyline this postseason: More players getting injured in fewer games. “Last year’s postseason [lasted] 89 games and finished with 109 man games lost […]